Protein expression levels were determined for the well-established biomarkers ER, PR, and HER2 as well as the nuclear hormone receptor AR (androgen receptor) that is discussed as a new clinically relevant biomarker and therapeutic target in BC [48]. This evidence concerns the gene ERBB2 and breast cancer.